Denka showcases cell culture ware: analysts target Denka stock at JPY 4,465

Published on 10/13/2026 at 00:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal 2027 first-quarter revenue reached JPY 96.98 billion, up 3.10 percent year over year. The average target for Denka stock is JPY 4,465.

Key points in brief

Denka showcased cell culture ware at BioJapan 2026 and presented a regenerative medicine application.
First-quarter fiscal 2027 revenue reached JPY 96.98 billion, up 3.10 percent year over year.
Yahoo Finance listed an average analyst target of JPY 4,465 for Denka stock.
The last Lang & Schwarz price was EUR 18.30 on October 12, 2026.

Denka, JP3549600009, Illustration mit AI erstellt.

Denka showcased cell culture ware for regenerative medicine at BioJapan 2026, and the average analyst target for Denka stock stood at JPY 4,465. The company announced the exhibition on October 1, 2026, while Yahoo Finance listed the target alongside a JPY 3,248 reference value dated October 9, 2026.

Three results shaped the picture

JPX Market Explorer reported that Denka posted JPY 384.247 billion in sales and JPY 15.695 billion in net income for the fiscal year ended March 31, 2026. Sales declined from JPY 400.251 billion, while net income recovered from a JPY 12.300 billion loss in the prior fiscal year.

For the first quarter of fiscal 2027, revenue reached JPY 96.977 billion and net income was JPY 2.843 billion, according to JPX Market Explorer. The comparison is mixed: revenue increased 3.10 percent year over year, while earnings per share fell 43.20 percent in the same quarter.

Cell culture ware adds a new angle

Denka's October 1 announcement covered cell culture ware under development for enhanced stem-cell differentiation. According to Denka, the product uses a polyrotaxane-coated surface and contains no animal-derived components. The company said the technology could shorten differentiation periods and reduce related cell-culture costs.

What comes next for earnings?

Yahoo Finance lists November 9, 2026 as Denka's next earnings date. That report will test whether the first-quarter revenue increase can continue while the gap between revenue growth and earnings performance narrows.

Chronology in three figures

On May 14, 2026, Denka reported fiscal-year sales of JPY 384.247 billion and net income of JPY 15.695 billion. On August 7, 2026, first-quarter fiscal 2027 revenue reached JPY 96.977 billion and net income reached JPY 2.843 billion, as reported by JPX Market Explorer. On October 1, 2026, Denka announced its BioJapan presentation for October 7 through October 9, 2026.

Dates and market context

BioJapan 2026 ran from October 7 through October 9, 2026, and the next earnings date listed for Denka is November 9, 2026. The Tokyo-listed company had a market capitalization of JPY 280.0 billion and a 52-week range of JPY 2,169.50 to JPY 4,692.00 as of October 9, 2026.

Last euro quote before publication

The last price at Lang & Schwarz was EUR 18.30 on October 12, 2026 at 10:57 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Denka stock.

Denka stock facts

Company: Denka Company Limited
ISIN: JP3549600009
Ticker: 4061
Primary exchange: Tokyo Stock Exchange Prime
Last Lang & Schwarz price as of October 12, 2026, 10:57 p.m. CEST: EUR 18.30
Market capitalization: JPY 280.0 billion as of October 9, 2026
52-week range: JPY 2,169.50-4,692.00 as of October 9, 2026
Sector / Industry: Basic Materials / Chemicals
Index membership: TOPIX Mid400
Next earnings date: November 9, 2026